These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20297853)

  • 1. Defining and measuring functional recovery from depression.
    Greer TL; Kurian BT; Trivedi MH
    CNS Drugs; 2010 Apr; 24(4):267-84. PubMed ID: 20297853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual residual symptoms and functional impairment in patients with depression.
    Romera I; Pérez V; Quail D; Berggren L; Lenox-Smith A; Gilaberte I
    Psychiatry Res; 2014 Dec; 220(1-2):258-62. PubMed ID: 25149132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of residual depressive symptoms and functional impairment between fully and partially remitted patients with major depressive disorder: a multicenter study.
    Xiao L; Feng L; Zhu XQ; Feng Y; Wu WY; Ungvari GS; Ng CH; Xiang YT; Wang G
    Psychiatry Res; 2018 Mar; 261():547-553. PubMed ID: 29407721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between residual symptoms of depression and self-reported cognitive impairment.
    Pedrelli P; Baer L; Losifescu DV; Fava M
    CNS Spectr; 2010 Jan; 15(1):46-51. PubMed ID: 20394184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring function in major depressive disorder: A systematic review.
    Sheehan DV; Nakagome K; Asami Y; Pappadopulos EA; Boucher M
    J Affect Disord; 2017 Jun; 215():299-313. PubMed ID: 28364701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive complaints are associated with depression, fatigue, female sex, and pain catastrophizing in patients with chronic pain.
    Roth RS; Geisser ME; Theisen-Goodvich M; Dixon PJ
    Arch Phys Med Rehabil; 2005 Jun; 86(6):1147-54. PubMed ID: 15954053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder.
    Aigner M; Förster-Streffleur S; Prause W; Freidl M; Weiss M; Bach M
    Soc Psychiatry Psychiatr Epidemiol; 2006 Jan; 41(1):81-6. PubMed ID: 16341612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective: remission of depression in primary care The Oreon Study.
    Ansseau M; Demyttenaere K; Heyrman J; Migeotte A; Leyman S; Mignon A
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):169-76. PubMed ID: 19144502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cognitive challenges in major depression: the role of the primary care physician.
    Mattingly G; Anderson RH; Mattingly SG; Anderson EQ
    Postgrad Med; 2016 Sep; 128(7):665-71. PubMed ID: 27500820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronobiology, cognitive function and depressive symptoms in surgical patients.
    Hansen MV
    Dan Med J; 2014 Sep; 61(9):B4914. PubMed ID: 25186550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual symptoms in depression: can treatment be symptom-specific?
    Menza M; Marin H; Opper RS
    J Clin Psychiatry; 2003 May; 64(5):516-23. PubMed ID: 12755653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness: the importance of psychosocial functioning outcomes.
    Lam RW; Filteau MJ; Milev R
    J Affect Disord; 2011 Aug; 132 Suppl 1():S9-S13. PubMed ID: 21514677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis.
    Guico-Pabia CJ; Fayyad RS; Soares CN
    Int Clin Psychopharmacol; 2012 Jan; 27(1):1-7. PubMed ID: 21971533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
    van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
    J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of treatment-resistant depression.
    Keitner GI; Mansfield AK
    Psychiatr Clin North Am; 2012 Mar; 35(1):249-65. PubMed ID: 22370501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.